nodes	percent_of_prediction	percent_of_DWPC	metapath
Levofloxacin—ABCB1—peripheral nervous system neoplasm	0.284	1	CbGaD
Levofloxacin—TOP2A—Epirubicin—peripheral nervous system neoplasm	0.0963	0.201	CbGbCtD
Levofloxacin—TOP2A—Etoposide—peripheral nervous system neoplasm	0.075	0.157	CbGbCtD
Levofloxacin—TOP2A—Doxorubicin—peripheral nervous system neoplasm	0.0512	0.107	CbGbCtD
Levofloxacin—SLC22A2—Cisplatin—peripheral nervous system neoplasm	0.0384	0.0802	CbGbCtD
Levofloxacin—CYP1A2—Alitretinoin—peripheral nervous system neoplasm	0.0293	0.0613	CbGbCtD
Levofloxacin—ABCB1—Topotecan—peripheral nervous system neoplasm	0.0257	0.0536	CbGbCtD
Levofloxacin—ABCB1—Alitretinoin—peripheral nervous system neoplasm	0.0257	0.0536	CbGbCtD
Levofloxacin—CYP1A2—Dacarbazine—peripheral nervous system neoplasm	0.0235	0.049	CbGbCtD
Levofloxacin—ABCB1—Dactinomycin—peripheral nervous system neoplasm	0.0178	0.0372	CbGbCtD
Levofloxacin—CYP3A4—Topotecan—peripheral nervous system neoplasm	0.0154	0.0321	CbGbCtD
Levofloxacin—CYP3A4—Tretinoin—peripheral nervous system neoplasm	0.0143	0.0299	CbGbCtD
Levofloxacin—CYP1A2—Etoposide—peripheral nervous system neoplasm	0.0115	0.024	CbGbCtD
Levofloxacin—ABCB1—Vincristine—peripheral nervous system neoplasm	0.011	0.0229	CbGbCtD
Levofloxacin—ABCB1—Cisplatin—peripheral nervous system neoplasm	0.0102	0.0213	CbGbCtD
Levofloxacin—ABCB1—Etoposide—peripheral nervous system neoplasm	0.01	0.021	CbGbCtD
Levofloxacin—ABCB1—Doxorubicin—peripheral nervous system neoplasm	0.00685	0.0143	CbGbCtD
Levofloxacin—CYP3A4—Vincristine—peripheral nervous system neoplasm	0.00656	0.0137	CbGbCtD
Levofloxacin—CYP3A4—Etoposide—peripheral nervous system neoplasm	0.00601	0.0126	CbGbCtD
Levofloxacin—CYP3A4—Doxorubicin—peripheral nervous system neoplasm	0.0041	0.00857	CbGbCtD
Levofloxacin—TOP2A—Irinotecan—Topotecan—peripheral nervous system neoplasm	0.000901	0.244	CbGdCrCtD
Levofloxacin—TOP2A—Vindesine—Vincristine—peripheral nervous system neoplasm	0.000535	0.145	CbGdCrCtD
Levofloxacin—TOP2A—Vinorelbine—Vincristine—peripheral nervous system neoplasm	0.000338	0.0913	CbGdCrCtD
Levofloxacin—TOP2A—Teniposide—Etoposide—peripheral nervous system neoplasm	0.000337	0.0913	CbGdCrCtD
Levofloxacin—TOP2A—Podofilox—Etoposide—peripheral nervous system neoplasm	0.000337	0.0913	CbGdCrCtD
Levofloxacin—TOP2A—Vinblastine—Vincristine—peripheral nervous system neoplasm	0.000232	0.0628	CbGdCrCtD
Levofloxacin—Sparfloxacin—ABCB1—peripheral nervous system neoplasm	0.000208	0.595	CrCbGaD
Levofloxacin—TOP2A—Idarubicin—Epirubicin—peripheral nervous system neoplasm	0.000176	0.0476	CbGdCrCtD
Levofloxacin—TOP2A—Daunorubicin—Epirubicin—peripheral nervous system neoplasm	0.000176	0.0476	CbGdCrCtD
Levofloxacin—TOP2A—Doxorubicin—Epirubicin—peripheral nervous system neoplasm	0.000176	0.0476	CbGdCrCtD
Levofloxacin—TOP2A—Idarubicin—Doxorubicin—peripheral nervous system neoplasm	0.000163	0.044	CbGdCrCtD
Levofloxacin—TOP2A—Epirubicin—Doxorubicin—peripheral nervous system neoplasm	0.000163	0.044	CbGdCrCtD
Levofloxacin—TOP2A—Daunorubicin—Doxorubicin—peripheral nervous system neoplasm	0.000163	0.044	CbGdCrCtD
Levofloxacin—Ciprofloxacin—ABCB1—peripheral nervous system neoplasm	0.000141	0.405	CrCbGaD
Levofloxacin—Gastrointestinal disorder—Etoposide—peripheral nervous system neoplasm	4.53e-05	0.000194	CcSEcCtD
Levofloxacin—Body temperature increased—Cisplatin—peripheral nervous system neoplasm	4.53e-05	0.000194	CcSEcCtD
Levofloxacin—Fatigue—Etoposide—peripheral nervous system neoplasm	4.52e-05	0.000194	CcSEcCtD
Levofloxacin—Neuropathy peripheral—Epirubicin—peripheral nervous system neoplasm	4.52e-05	0.000194	CcSEcCtD
Levofloxacin—Stomatitis—Epirubicin—peripheral nervous system neoplasm	4.49e-05	0.000193	CcSEcCtD
Levofloxacin—Jaundice—Epirubicin—peripheral nervous system neoplasm	4.49e-05	0.000193	CcSEcCtD
Levofloxacin—Constipation—Etoposide—peripheral nervous system neoplasm	4.49e-05	0.000192	CcSEcCtD
Levofloxacin—Pain—Etoposide—peripheral nervous system neoplasm	4.49e-05	0.000192	CcSEcCtD
Levofloxacin—Conjunctivitis—Epirubicin—peripheral nervous system neoplasm	4.48e-05	0.000192	CcSEcCtD
Levofloxacin—Neutropenia—Doxorubicin—peripheral nervous system neoplasm	4.47e-05	0.000192	CcSEcCtD
Levofloxacin—Dysuria—Doxorubicin—peripheral nervous system neoplasm	4.47e-05	0.000192	CcSEcCtD
Levofloxacin—Upper respiratory tract infection—Doxorubicin—peripheral nervous system neoplasm	4.45e-05	0.000191	CcSEcCtD
Levofloxacin—Dizziness—Alitretinoin—peripheral nervous system neoplasm	4.44e-05	0.00019	CcSEcCtD
Levofloxacin—Diarrhoea—Vincristine—peripheral nervous system neoplasm	4.43e-05	0.00019	CcSEcCtD
Levofloxacin—Pollakiuria—Doxorubicin—peripheral nervous system neoplasm	4.42e-05	0.000189	CcSEcCtD
Levofloxacin—Haematuria—Epirubicin—peripheral nervous system neoplasm	4.4e-05	0.000188	CcSEcCtD
Levofloxacin—Photosensitivity reaction—Doxorubicin—peripheral nervous system neoplasm	4.37e-05	0.000187	CcSEcCtD
Levofloxacin—Hepatobiliary disease—Epirubicin—peripheral nervous system neoplasm	4.36e-05	0.000187	CcSEcCtD
Levofloxacin—Epistaxis—Epirubicin—peripheral nervous system neoplasm	4.35e-05	0.000186	CcSEcCtD
Levofloxacin—Weight decreased—Doxorubicin—peripheral nervous system neoplasm	4.33e-05	0.000186	CcSEcCtD
Levofloxacin—Sinusitis—Epirubicin—peripheral nervous system neoplasm	4.33e-05	0.000185	CcSEcCtD
Levofloxacin—Feeling abnormal—Etoposide—peripheral nervous system neoplasm	4.32e-05	0.000185	CcSEcCtD
Levofloxacin—Hyperglycaemia—Doxorubicin—peripheral nervous system neoplasm	4.32e-05	0.000185	CcSEcCtD
Levofloxacin—Nausea—Dactinomycin—peripheral nervous system neoplasm	4.31e-05	0.000185	CcSEcCtD
Levofloxacin—Agranulocytosis—Epirubicin—peripheral nervous system neoplasm	4.3e-05	0.000184	CcSEcCtD
Levofloxacin—Pneumonia—Doxorubicin—peripheral nervous system neoplasm	4.29e-05	0.000184	CcSEcCtD
Levofloxacin—Gastrointestinal pain—Etoposide—peripheral nervous system neoplasm	4.29e-05	0.000184	CcSEcCtD
Levofloxacin—Dizziness—Vincristine—peripheral nervous system neoplasm	4.28e-05	0.000184	CcSEcCtD
Levofloxacin—Vomiting—Alitretinoin—peripheral nervous system neoplasm	4.27e-05	0.000183	CcSEcCtD
Levofloxacin—Infestation NOS—Doxorubicin—peripheral nervous system neoplasm	4.27e-05	0.000183	CcSEcCtD
Levofloxacin—Drowsiness—Doxorubicin—peripheral nervous system neoplasm	4.27e-05	0.000183	CcSEcCtD
Levofloxacin—Infestation—Doxorubicin—peripheral nervous system neoplasm	4.27e-05	0.000183	CcSEcCtD
Levofloxacin—Rash—Alitretinoin—peripheral nervous system neoplasm	4.24e-05	0.000182	CcSEcCtD
Levofloxacin—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	4.23e-05	0.000181	CcSEcCtD
Levofloxacin—Stevens-Johnson syndrome—Doxorubicin—peripheral nervous system neoplasm	4.23e-05	0.000181	CcSEcCtD
Levofloxacin—Hypersensitivity—Cisplatin—peripheral nervous system neoplasm	4.22e-05	0.000181	CcSEcCtD
Levofloxacin—Bradycardia—Epirubicin—peripheral nervous system neoplasm	4.21e-05	0.000181	CcSEcCtD
Levofloxacin—Headache—Alitretinoin—peripheral nervous system neoplasm	4.21e-05	0.00018	CcSEcCtD
Levofloxacin—Renal failure—Doxorubicin—peripheral nervous system neoplasm	4.19e-05	0.00018	CcSEcCtD
Levofloxacin—Neuropathy peripheral—Doxorubicin—peripheral nervous system neoplasm	4.18e-05	0.000179	CcSEcCtD
Levofloxacin—Urticaria—Etoposide—peripheral nervous system neoplasm	4.17e-05	0.000179	CcSEcCtD
Levofloxacin—Haemoglobin—Epirubicin—peripheral nervous system neoplasm	4.16e-05	0.000178	CcSEcCtD
Levofloxacin—Stomatitis—Doxorubicin—peripheral nervous system neoplasm	4.16e-05	0.000178	CcSEcCtD
Levofloxacin—Jaundice—Doxorubicin—peripheral nervous system neoplasm	4.16e-05	0.000178	CcSEcCtD
Levofloxacin—Rhinitis—Epirubicin—peripheral nervous system neoplasm	4.15e-05	0.000178	CcSEcCtD
Levofloxacin—Abdominal pain—Etoposide—peripheral nervous system neoplasm	4.15e-05	0.000178	CcSEcCtD
Levofloxacin—Body temperature increased—Etoposide—peripheral nervous system neoplasm	4.15e-05	0.000178	CcSEcCtD
Levofloxacin—Conjunctivitis—Doxorubicin—peripheral nervous system neoplasm	4.15e-05	0.000178	CcSEcCtD
Levofloxacin—Haemorrhage—Epirubicin—peripheral nervous system neoplasm	4.14e-05	0.000177	CcSEcCtD
Levofloxacin—Hepatitis—Epirubicin—peripheral nervous system neoplasm	4.14e-05	0.000177	CcSEcCtD
Levofloxacin—Hypoaesthesia—Epirubicin—peripheral nervous system neoplasm	4.12e-05	0.000177	CcSEcCtD
Levofloxacin—Vomiting—Vincristine—peripheral nervous system neoplasm	4.12e-05	0.000176	CcSEcCtD
Levofloxacin—Asthenia—Cisplatin—peripheral nervous system neoplasm	4.11e-05	0.000176	CcSEcCtD
Levofloxacin—Pharyngitis—Epirubicin—peripheral nervous system neoplasm	4.11e-05	0.000176	CcSEcCtD
Levofloxacin—Urinary tract disorder—Epirubicin—peripheral nervous system neoplasm	4.09e-05	0.000175	CcSEcCtD
Levofloxacin—Rash—Vincristine—peripheral nervous system neoplasm	4.08e-05	0.000175	CcSEcCtD
Levofloxacin—Dermatitis—Vincristine—peripheral nervous system neoplasm	4.08e-05	0.000175	CcSEcCtD
Levofloxacin—Oedema peripheral—Epirubicin—peripheral nervous system neoplasm	4.08e-05	0.000175	CcSEcCtD
Levofloxacin—Haematuria—Doxorubicin—peripheral nervous system neoplasm	4.07e-05	0.000174	CcSEcCtD
Levofloxacin—Connective tissue disorder—Epirubicin—peripheral nervous system neoplasm	4.07e-05	0.000174	CcSEcCtD
Levofloxacin—Urethral disorder—Epirubicin—peripheral nervous system neoplasm	4.06e-05	0.000174	CcSEcCtD
Levofloxacin—Headache—Vincristine—peripheral nervous system neoplasm	4.06e-05	0.000174	CcSEcCtD
Levofloxacin—Hepatobiliary disease—Doxorubicin—peripheral nervous system neoplasm	4.03e-05	0.000173	CcSEcCtD
Levofloxacin—Epistaxis—Doxorubicin—peripheral nervous system neoplasm	4.02e-05	0.000172	CcSEcCtD
Levofloxacin—Sinusitis—Doxorubicin—peripheral nervous system neoplasm	4e-05	0.000172	CcSEcCtD
Levofloxacin—Nausea—Alitretinoin—peripheral nervous system neoplasm	3.99e-05	0.000171	CcSEcCtD
Levofloxacin—Visual impairment—Epirubicin—peripheral nervous system neoplasm	3.99e-05	0.000171	CcSEcCtD
Levofloxacin—Agranulocytosis—Doxorubicin—peripheral nervous system neoplasm	3.98e-05	0.000171	CcSEcCtD
Levofloxacin—Diarrhoea—Cisplatin—peripheral nervous system neoplasm	3.92e-05	0.000168	CcSEcCtD
Levofloxacin—Erythema multiforme—Epirubicin—peripheral nervous system neoplasm	3.91e-05	0.000168	CcSEcCtD
Levofloxacin—Bradycardia—Doxorubicin—peripheral nervous system neoplasm	3.9e-05	0.000167	CcSEcCtD
Levofloxacin—Eye disorder—Epirubicin—peripheral nervous system neoplasm	3.87e-05	0.000166	CcSEcCtD
Levofloxacin—Hypersensitivity—Etoposide—peripheral nervous system neoplasm	3.86e-05	0.000166	CcSEcCtD
Levofloxacin—Tinnitus—Epirubicin—peripheral nervous system neoplasm	3.86e-05	0.000165	CcSEcCtD
Levofloxacin—Haemoglobin—Doxorubicin—peripheral nervous system neoplasm	3.85e-05	0.000165	CcSEcCtD
Levofloxacin—Nausea—Vincristine—peripheral nervous system neoplasm	3.85e-05	0.000165	CcSEcCtD
Levofloxacin—Cardiac disorder—Epirubicin—peripheral nervous system neoplasm	3.84e-05	0.000165	CcSEcCtD
Levofloxacin—Flushing—Epirubicin—peripheral nervous system neoplasm	3.84e-05	0.000165	CcSEcCtD
Levofloxacin—Rhinitis—Doxorubicin—peripheral nervous system neoplasm	3.84e-05	0.000165	CcSEcCtD
Levofloxacin—Hepatitis—Doxorubicin—peripheral nervous system neoplasm	3.83e-05	0.000164	CcSEcCtD
Levofloxacin—Haemorrhage—Doxorubicin—peripheral nervous system neoplasm	3.83e-05	0.000164	CcSEcCtD
Levofloxacin—Hypoaesthesia—Doxorubicin—peripheral nervous system neoplasm	3.81e-05	0.000163	CcSEcCtD
Levofloxacin—Pharyngitis—Doxorubicin—peripheral nervous system neoplasm	3.8e-05	0.000163	CcSEcCtD
Levofloxacin—Urinary tract disorder—Doxorubicin—peripheral nervous system neoplasm	3.78e-05	0.000162	CcSEcCtD
Levofloxacin—Oedema peripheral—Doxorubicin—peripheral nervous system neoplasm	3.77e-05	0.000162	CcSEcCtD
Levofloxacin—Asthenia—Etoposide—peripheral nervous system neoplasm	3.76e-05	0.000161	CcSEcCtD
Levofloxacin—Connective tissue disorder—Doxorubicin—peripheral nervous system neoplasm	3.76e-05	0.000161	CcSEcCtD
Levofloxacin—Angiopathy—Epirubicin—peripheral nervous system neoplasm	3.76e-05	0.000161	CcSEcCtD
Levofloxacin—Urethral disorder—Doxorubicin—peripheral nervous system neoplasm	3.75e-05	0.000161	CcSEcCtD
Levofloxacin—Immune system disorder—Epirubicin—peripheral nervous system neoplasm	3.74e-05	0.00016	CcSEcCtD
Levofloxacin—Mediastinal disorder—Epirubicin—peripheral nervous system neoplasm	3.73e-05	0.00016	CcSEcCtD
Levofloxacin—Chills—Epirubicin—peripheral nervous system neoplasm	3.71e-05	0.000159	CcSEcCtD
Levofloxacin—Pruritus—Etoposide—peripheral nervous system neoplasm	3.71e-05	0.000159	CcSEcCtD
Levofloxacin—Arrhythmia—Epirubicin—peripheral nervous system neoplasm	3.7e-05	0.000158	CcSEcCtD
Levofloxacin—Visual impairment—Doxorubicin—peripheral nervous system neoplasm	3.69e-05	0.000158	CcSEcCtD
Levofloxacin—Alopecia—Epirubicin—peripheral nervous system neoplasm	3.66e-05	0.000157	CcSEcCtD
Levofloxacin—Vomiting—Cisplatin—peripheral nervous system neoplasm	3.64e-05	0.000156	CcSEcCtD
Levofloxacin—Mental disorder—Epirubicin—peripheral nervous system neoplasm	3.63e-05	0.000155	CcSEcCtD
Levofloxacin—Erythema multiforme—Doxorubicin—peripheral nervous system neoplasm	3.62e-05	0.000155	CcSEcCtD
Levofloxacin—Rash—Cisplatin—peripheral nervous system neoplasm	3.61e-05	0.000155	CcSEcCtD
Levofloxacin—Dermatitis—Cisplatin—peripheral nervous system neoplasm	3.61e-05	0.000155	CcSEcCtD
Levofloxacin—Erythema—Epirubicin—peripheral nervous system neoplasm	3.6e-05	0.000154	CcSEcCtD
Levofloxacin—Malnutrition—Epirubicin—peripheral nervous system neoplasm	3.6e-05	0.000154	CcSEcCtD
Levofloxacin—Diarrhoea—Etoposide—peripheral nervous system neoplasm	3.59e-05	0.000154	CcSEcCtD
Levofloxacin—Eye disorder—Doxorubicin—peripheral nervous system neoplasm	3.58e-05	0.000153	CcSEcCtD
Levofloxacin—Tinnitus—Doxorubicin—peripheral nervous system neoplasm	3.57e-05	0.000153	CcSEcCtD
Levofloxacin—Flushing—Doxorubicin—peripheral nervous system neoplasm	3.55e-05	0.000152	CcSEcCtD
Levofloxacin—Cardiac disorder—Doxorubicin—peripheral nervous system neoplasm	3.55e-05	0.000152	CcSEcCtD
Levofloxacin—Flatulence—Epirubicin—peripheral nervous system neoplasm	3.55e-05	0.000152	CcSEcCtD
Levofloxacin—Tension—Epirubicin—peripheral nervous system neoplasm	3.54e-05	0.000152	CcSEcCtD
Levofloxacin—Dysgeusia—Epirubicin—peripheral nervous system neoplasm	3.53e-05	0.000151	CcSEcCtD
Levofloxacin—Nervousness—Epirubicin—peripheral nervous system neoplasm	3.5e-05	0.00015	CcSEcCtD
Levofloxacin—Back pain—Epirubicin—peripheral nervous system neoplasm	3.49e-05	0.000149	CcSEcCtD
Levofloxacin—Angiopathy—Doxorubicin—peripheral nervous system neoplasm	3.47e-05	0.000149	CcSEcCtD
Levofloxacin—Dizziness—Etoposide—peripheral nervous system neoplasm	3.47e-05	0.000149	CcSEcCtD
Levofloxacin—Muscle spasms—Epirubicin—peripheral nervous system neoplasm	3.46e-05	0.000148	CcSEcCtD
Levofloxacin—Immune system disorder—Doxorubicin—peripheral nervous system neoplasm	3.46e-05	0.000148	CcSEcCtD
Levofloxacin—Mediastinal disorder—Doxorubicin—peripheral nervous system neoplasm	3.45e-05	0.000148	CcSEcCtD
Levofloxacin—Chills—Doxorubicin—peripheral nervous system neoplasm	3.44e-05	0.000147	CcSEcCtD
Levofloxacin—Arrhythmia—Doxorubicin—peripheral nervous system neoplasm	3.42e-05	0.000147	CcSEcCtD
Levofloxacin—Nausea—Cisplatin—peripheral nervous system neoplasm	3.4e-05	0.000146	CcSEcCtD
Levofloxacin—Vision blurred—Epirubicin—peripheral nervous system neoplasm	3.4e-05	0.000146	CcSEcCtD
Levofloxacin—Alopecia—Doxorubicin—peripheral nervous system neoplasm	3.38e-05	0.000145	CcSEcCtD
Levofloxacin—Mental disorder—Doxorubicin—peripheral nervous system neoplasm	3.36e-05	0.000144	CcSEcCtD
Levofloxacin—Ill-defined disorder—Epirubicin—peripheral nervous system neoplasm	3.34e-05	0.000143	CcSEcCtD
Levofloxacin—Vomiting—Etoposide—peripheral nervous system neoplasm	3.34e-05	0.000143	CcSEcCtD
Levofloxacin—Erythema—Doxorubicin—peripheral nervous system neoplasm	3.33e-05	0.000143	CcSEcCtD
Levofloxacin—Malnutrition—Doxorubicin—peripheral nervous system neoplasm	3.33e-05	0.000143	CcSEcCtD
Levofloxacin—Anaemia—Epirubicin—peripheral nervous system neoplasm	3.33e-05	0.000143	CcSEcCtD
Levofloxacin—Agitation—Epirubicin—peripheral nervous system neoplasm	3.31e-05	0.000142	CcSEcCtD
Levofloxacin—Rash—Etoposide—peripheral nervous system neoplasm	3.31e-05	0.000142	CcSEcCtD
Levofloxacin—Dermatitis—Etoposide—peripheral nervous system neoplasm	3.3e-05	0.000142	CcSEcCtD
Levofloxacin—Headache—Etoposide—peripheral nervous system neoplasm	3.29e-05	0.000141	CcSEcCtD
Levofloxacin—Flatulence—Doxorubicin—peripheral nervous system neoplasm	3.29e-05	0.000141	CcSEcCtD
Levofloxacin—Tension—Doxorubicin—peripheral nervous system neoplasm	3.27e-05	0.00014	CcSEcCtD
Levofloxacin—Dysgeusia—Doxorubicin—peripheral nervous system neoplasm	3.26e-05	0.00014	CcSEcCtD
Levofloxacin—Malaise—Epirubicin—peripheral nervous system neoplasm	3.25e-05	0.000139	CcSEcCtD
Levofloxacin—Nervousness—Doxorubicin—peripheral nervous system neoplasm	3.24e-05	0.000139	CcSEcCtD
Levofloxacin—Vertigo—Epirubicin—peripheral nervous system neoplasm	3.24e-05	0.000139	CcSEcCtD
Levofloxacin—Syncope—Epirubicin—peripheral nervous system neoplasm	3.23e-05	0.000138	CcSEcCtD
Levofloxacin—Leukopenia—Epirubicin—peripheral nervous system neoplasm	3.23e-05	0.000138	CcSEcCtD
Levofloxacin—Back pain—Doxorubicin—peripheral nervous system neoplasm	3.22e-05	0.000138	CcSEcCtD
Levofloxacin—Muscle spasms—Doxorubicin—peripheral nervous system neoplasm	3.21e-05	0.000137	CcSEcCtD
Levofloxacin—Palpitations—Epirubicin—peripheral nervous system neoplasm	3.18e-05	0.000136	CcSEcCtD
Levofloxacin—Loss of consciousness—Epirubicin—peripheral nervous system neoplasm	3.17e-05	0.000136	CcSEcCtD
Levofloxacin—Cough—Epirubicin—peripheral nervous system neoplasm	3.14e-05	0.000135	CcSEcCtD
Levofloxacin—Vision blurred—Doxorubicin—peripheral nervous system neoplasm	3.14e-05	0.000135	CcSEcCtD
Levofloxacin—Nausea—Etoposide—peripheral nervous system neoplasm	3.12e-05	0.000134	CcSEcCtD
Levofloxacin—Hypertension—Epirubicin—peripheral nervous system neoplasm	3.11e-05	0.000133	CcSEcCtD
Levofloxacin—Ill-defined disorder—Doxorubicin—peripheral nervous system neoplasm	3.09e-05	0.000133	CcSEcCtD
Levofloxacin—Anaemia—Doxorubicin—peripheral nervous system neoplasm	3.08e-05	0.000132	CcSEcCtD
Levofloxacin—Myalgia—Epirubicin—peripheral nervous system neoplasm	3.07e-05	0.000131	CcSEcCtD
Levofloxacin—Arthralgia—Epirubicin—peripheral nervous system neoplasm	3.07e-05	0.000131	CcSEcCtD
Levofloxacin—Chest pain—Epirubicin—peripheral nervous system neoplasm	3.07e-05	0.000131	CcSEcCtD
Levofloxacin—Agitation—Doxorubicin—peripheral nervous system neoplasm	3.06e-05	0.000131	CcSEcCtD
Levofloxacin—Anxiety—Epirubicin—peripheral nervous system neoplasm	3.06e-05	0.000131	CcSEcCtD
Levofloxacin—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—peripheral nervous system neoplasm	3.05e-05	0.000131	CcSEcCtD
Levofloxacin—Discomfort—Epirubicin—peripheral nervous system neoplasm	3.03e-05	0.00013	CcSEcCtD
Levofloxacin—Malaise—Doxorubicin—peripheral nervous system neoplasm	3.01e-05	0.000129	CcSEcCtD
Levofloxacin—Dry mouth—Epirubicin—peripheral nervous system neoplasm	3e-05	0.000129	CcSEcCtD
Levofloxacin—Vertigo—Doxorubicin—peripheral nervous system neoplasm	3e-05	0.000128	CcSEcCtD
Levofloxacin—Syncope—Doxorubicin—peripheral nervous system neoplasm	2.99e-05	0.000128	CcSEcCtD
Levofloxacin—Leukopenia—Doxorubicin—peripheral nervous system neoplasm	2.98e-05	0.000128	CcSEcCtD
Levofloxacin—Confusional state—Epirubicin—peripheral nervous system neoplasm	2.97e-05	0.000127	CcSEcCtD
Levofloxacin—Palpitations—Doxorubicin—peripheral nervous system neoplasm	2.95e-05	0.000126	CcSEcCtD
Levofloxacin—Anaphylactic shock—Epirubicin—peripheral nervous system neoplasm	2.94e-05	0.000126	CcSEcCtD
Levofloxacin—Oedema—Epirubicin—peripheral nervous system neoplasm	2.94e-05	0.000126	CcSEcCtD
Levofloxacin—Loss of consciousness—Doxorubicin—peripheral nervous system neoplasm	2.93e-05	0.000126	CcSEcCtD
Levofloxacin—Infection—Epirubicin—peripheral nervous system neoplasm	2.92e-05	0.000125	CcSEcCtD
Levofloxacin—Cough—Doxorubicin—peripheral nervous system neoplasm	2.91e-05	0.000125	CcSEcCtD
Levofloxacin—Shock—Epirubicin—peripheral nervous system neoplasm	2.89e-05	0.000124	CcSEcCtD
Levofloxacin—Nervous system disorder—Epirubicin—peripheral nervous system neoplasm	2.88e-05	0.000124	CcSEcCtD
Levofloxacin—Thrombocytopenia—Epirubicin—peripheral nervous system neoplasm	2.88e-05	0.000123	CcSEcCtD
Levofloxacin—Hypertension—Doxorubicin—peripheral nervous system neoplasm	2.88e-05	0.000123	CcSEcCtD
Levofloxacin—Tachycardia—Epirubicin—peripheral nervous system neoplasm	2.87e-05	0.000123	CcSEcCtD
Levofloxacin—Skin disorder—Epirubicin—peripheral nervous system neoplasm	2.86e-05	0.000122	CcSEcCtD
Levofloxacin—Hyperhidrosis—Epirubicin—peripheral nervous system neoplasm	2.84e-05	0.000122	CcSEcCtD
Levofloxacin—Chest pain—Doxorubicin—peripheral nervous system neoplasm	2.84e-05	0.000122	CcSEcCtD
Levofloxacin—Myalgia—Doxorubicin—peripheral nervous system neoplasm	2.84e-05	0.000122	CcSEcCtD
Levofloxacin—Arthralgia—Doxorubicin—peripheral nervous system neoplasm	2.84e-05	0.000122	CcSEcCtD
Levofloxacin—Anxiety—Doxorubicin—peripheral nervous system neoplasm	2.83e-05	0.000121	CcSEcCtD
Levofloxacin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—peripheral nervous system neoplasm	2.82e-05	0.000121	CcSEcCtD
Levofloxacin—Discomfort—Doxorubicin—peripheral nervous system neoplasm	2.8e-05	0.00012	CcSEcCtD
Levofloxacin—Anorexia—Epirubicin—peripheral nervous system neoplasm	2.8e-05	0.00012	CcSEcCtD
Levofloxacin—Dry mouth—Doxorubicin—peripheral nervous system neoplasm	2.78e-05	0.000119	CcSEcCtD
Levofloxacin—Hypotension—Epirubicin—peripheral nervous system neoplasm	2.75e-05	0.000118	CcSEcCtD
Levofloxacin—Confusional state—Doxorubicin—peripheral nervous system neoplasm	2.74e-05	0.000118	CcSEcCtD
Levofloxacin—Oedema—Doxorubicin—peripheral nervous system neoplasm	2.72e-05	0.000117	CcSEcCtD
Levofloxacin—Anaphylactic shock—Doxorubicin—peripheral nervous system neoplasm	2.72e-05	0.000117	CcSEcCtD
Levofloxacin—Infection—Doxorubicin—peripheral nervous system neoplasm	2.7e-05	0.000116	CcSEcCtD
Levofloxacin—Musculoskeletal discomfort—Epirubicin—peripheral nervous system neoplasm	2.68e-05	0.000115	CcSEcCtD
Levofloxacin—Shock—Doxorubicin—peripheral nervous system neoplasm	2.68e-05	0.000115	CcSEcCtD
Levofloxacin—Nervous system disorder—Doxorubicin—peripheral nervous system neoplasm	2.67e-05	0.000114	CcSEcCtD
Levofloxacin—Thrombocytopenia—Doxorubicin—peripheral nervous system neoplasm	2.66e-05	0.000114	CcSEcCtD
Levofloxacin—Insomnia—Epirubicin—peripheral nervous system neoplasm	2.66e-05	0.000114	CcSEcCtD
Levofloxacin—Tachycardia—Doxorubicin—peripheral nervous system neoplasm	2.66e-05	0.000114	CcSEcCtD
Levofloxacin—Skin disorder—Doxorubicin—peripheral nervous system neoplasm	2.64e-05	0.000113	CcSEcCtD
Levofloxacin—Paraesthesia—Epirubicin—peripheral nervous system neoplasm	2.64e-05	0.000113	CcSEcCtD
Levofloxacin—Hyperhidrosis—Doxorubicin—peripheral nervous system neoplasm	2.63e-05	0.000113	CcSEcCtD
Levofloxacin—Dyspnoea—Epirubicin—peripheral nervous system neoplasm	2.62e-05	0.000112	CcSEcCtD
Levofloxacin—Somnolence—Epirubicin—peripheral nervous system neoplasm	2.61e-05	0.000112	CcSEcCtD
Levofloxacin—Anorexia—Doxorubicin—peripheral nervous system neoplasm	2.59e-05	0.000111	CcSEcCtD
Levofloxacin—Dyspepsia—Epirubicin—peripheral nervous system neoplasm	2.59e-05	0.000111	CcSEcCtD
Levofloxacin—Decreased appetite—Epirubicin—peripheral nervous system neoplasm	2.56e-05	0.00011	CcSEcCtD
Levofloxacin—Hypotension—Doxorubicin—peripheral nervous system neoplasm	2.54e-05	0.000109	CcSEcCtD
Levofloxacin—Gastrointestinal disorder—Epirubicin—peripheral nervous system neoplasm	2.54e-05	0.000109	CcSEcCtD
Levofloxacin—Fatigue—Epirubicin—peripheral nervous system neoplasm	2.54e-05	0.000109	CcSEcCtD
Levofloxacin—Pain—Epirubicin—peripheral nervous system neoplasm	2.51e-05	0.000108	CcSEcCtD
Levofloxacin—Constipation—Epirubicin—peripheral nervous system neoplasm	2.51e-05	0.000108	CcSEcCtD
Levofloxacin—Musculoskeletal discomfort—Doxorubicin—peripheral nervous system neoplasm	2.48e-05	0.000106	CcSEcCtD
Levofloxacin—Insomnia—Doxorubicin—peripheral nervous system neoplasm	2.46e-05	0.000105	CcSEcCtD
Levofloxacin—Paraesthesia—Doxorubicin—peripheral nervous system neoplasm	2.44e-05	0.000105	CcSEcCtD
Levofloxacin—Dyspnoea—Doxorubicin—peripheral nervous system neoplasm	2.43e-05	0.000104	CcSEcCtD
Levofloxacin—Feeling abnormal—Epirubicin—peripheral nervous system neoplasm	2.42e-05	0.000104	CcSEcCtD
Levofloxacin—Somnolence—Doxorubicin—peripheral nervous system neoplasm	2.42e-05	0.000104	CcSEcCtD
Levofloxacin—Gastrointestinal pain—Epirubicin—peripheral nervous system neoplasm	2.4e-05	0.000103	CcSEcCtD
Levofloxacin—Dyspepsia—Doxorubicin—peripheral nervous system neoplasm	2.4e-05	0.000103	CcSEcCtD
Levofloxacin—Decreased appetite—Doxorubicin—peripheral nervous system neoplasm	2.37e-05	0.000101	CcSEcCtD
Levofloxacin—Gastrointestinal disorder—Doxorubicin—peripheral nervous system neoplasm	2.35e-05	0.000101	CcSEcCtD
Levofloxacin—Fatigue—Doxorubicin—peripheral nervous system neoplasm	2.35e-05	0.000101	CcSEcCtD
Levofloxacin—Urticaria—Epirubicin—peripheral nervous system neoplasm	2.34e-05	0.0001	CcSEcCtD
Levofloxacin—Pain—Doxorubicin—peripheral nervous system neoplasm	2.33e-05	9.97e-05	CcSEcCtD
Levofloxacin—Constipation—Doxorubicin—peripheral nervous system neoplasm	2.33e-05	9.97e-05	CcSEcCtD
Levofloxacin—Abdominal pain—Epirubicin—peripheral nervous system neoplasm	2.32e-05	9.96e-05	CcSEcCtD
Levofloxacin—Body temperature increased—Epirubicin—peripheral nervous system neoplasm	2.32e-05	9.96e-05	CcSEcCtD
Levofloxacin—Feeling abnormal—Doxorubicin—peripheral nervous system neoplasm	2.24e-05	9.61e-05	CcSEcCtD
Levofloxacin—Gastrointestinal pain—Doxorubicin—peripheral nervous system neoplasm	2.22e-05	9.54e-05	CcSEcCtD
Levofloxacin—Hypersensitivity—Epirubicin—peripheral nervous system neoplasm	2.17e-05	9.29e-05	CcSEcCtD
Levofloxacin—Urticaria—Doxorubicin—peripheral nervous system neoplasm	2.16e-05	9.26e-05	CcSEcCtD
Levofloxacin—Body temperature increased—Doxorubicin—peripheral nervous system neoplasm	2.15e-05	9.22e-05	CcSEcCtD
Levofloxacin—Abdominal pain—Doxorubicin—peripheral nervous system neoplasm	2.15e-05	9.22e-05	CcSEcCtD
Levofloxacin—Asthenia—Epirubicin—peripheral nervous system neoplasm	2.11e-05	9.04e-05	CcSEcCtD
Levofloxacin—Pruritus—Epirubicin—peripheral nervous system neoplasm	2.08e-05	8.92e-05	CcSEcCtD
Levofloxacin—Diarrhoea—Epirubicin—peripheral nervous system neoplasm	2.01e-05	8.62e-05	CcSEcCtD
Levofloxacin—Hypersensitivity—Doxorubicin—peripheral nervous system neoplasm	2e-05	8.59e-05	CcSEcCtD
Levofloxacin—Asthenia—Doxorubicin—peripheral nervous system neoplasm	1.95e-05	8.37e-05	CcSEcCtD
Levofloxacin—Dizziness—Epirubicin—peripheral nervous system neoplasm	1.94e-05	8.33e-05	CcSEcCtD
Levofloxacin—Pruritus—Doxorubicin—peripheral nervous system neoplasm	1.92e-05	8.25e-05	CcSEcCtD
Levofloxacin—Vomiting—Epirubicin—peripheral nervous system neoplasm	1.87e-05	8.01e-05	CcSEcCtD
Levofloxacin—Diarrhoea—Doxorubicin—peripheral nervous system neoplasm	1.86e-05	7.98e-05	CcSEcCtD
Levofloxacin—Rash—Epirubicin—peripheral nervous system neoplasm	1.85e-05	7.95e-05	CcSEcCtD
Levofloxacin—Dermatitis—Epirubicin—peripheral nervous system neoplasm	1.85e-05	7.94e-05	CcSEcCtD
Levofloxacin—Headache—Epirubicin—peripheral nervous system neoplasm	1.84e-05	7.9e-05	CcSEcCtD
Levofloxacin—Dizziness—Doxorubicin—peripheral nervous system neoplasm	1.8e-05	7.71e-05	CcSEcCtD
Levofloxacin—Nausea—Epirubicin—peripheral nervous system neoplasm	1.75e-05	7.49e-05	CcSEcCtD
Levofloxacin—Vomiting—Doxorubicin—peripheral nervous system neoplasm	1.73e-05	7.41e-05	CcSEcCtD
Levofloxacin—Rash—Doxorubicin—peripheral nervous system neoplasm	1.72e-05	7.35e-05	CcSEcCtD
Levofloxacin—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	1.71e-05	7.35e-05	CcSEcCtD
Levofloxacin—Headache—Doxorubicin—peripheral nervous system neoplasm	1.7e-05	7.31e-05	CcSEcCtD
Levofloxacin—Nausea—Doxorubicin—peripheral nervous system neoplasm	1.62e-05	6.93e-05	CcSEcCtD
